American Century Companies
HZNP

American Century Companies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American Century Companies’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,061
Closed -$3.13M – 2959
2023
Q3 		$3.13M Buy
27,061
+684
+3% +$73.5K ﹤0.01% 1519
2023
Q2 		$2.71M Sell
26,377
-8,380
-24% -$884K ﹤0.01% 1539
2023
Q1 		$3.77M Sell
34,757
-349,184
-91% -$38.6M ﹤0.01% 1363
2022
Q4 		$43.7M Sell
383,941
-1,053,539
-73% -$87.5M 0.04% 456
2022
Q3 		$89M Buy
1,437,480
+198,623
+16% +$13.9M 0.08% 279
2022
Q2 		$98.8M Buy
1,238,857
+130,660
+12% +$12.4M 0.08% 267
2022
Q1 		$117M Buy
1,108,197
+129,708
+13% +$12.6M 0.08% 268
2021
Q4 		$105M Sell
978,489
-421,599
-30% -$46M 0.07% 305
2021
Q3 		$153M Buy
1,400,088
+426,667
+44% +$44.3M 0.11% 193
2021
Q2 		$91.2M Sell
973,421
-446,197
-31% -$41.1M 0.06% 331
2021
Q1 		$131M Buy
1,419,618
+306,417
+28% +$25.9M 0.1% 245
2020
Q4 		$81.4M Sell
1,113,201
-126,607
-10% -$9.41M 0.06% 296
2020
Q3 		$96.3M Buy
1,239,808
+2,645
+0.2% +$182K 0.09% 261
2020
Q2 		$68.8M Buy
1,237,163
+886,320
+253% +$37.9M 0.07% 280
2020
Q1 		$10.4M Sell
350,843
-144,721
-29% -$4.9M 0.01% 595
2019
Q4 		$17.9M Buy
495,564
+61,025
+14% +$1.87M 0.02% 543
2019
Q3 		$11.8M Sell
434,539
-195,203
-31% -$5.05M 0.01% 584
2019
Q2 		$15.2M Buy
629,742
+67,009
+12% +$1.7M 0.02% 552
2019
Q1 		$14.9M Sell
562,733
-21,581
-4% -$511K 0.02% 538
2018
Q4 		$11.4M Sell
584,314
-73,624
-11% -$1.44M 0.01% 577
2018
Q3 		$12.9M Sell
657,938
-39,555
-6% -$752K 0.01% 575
2018
Q2 		$11.6M Sell
697,493
-9,282
-1% -$142K 0.01% 616
2018
Q1 		$10M Buy
706,775
+433,359
+158% +$6.4M 0.01% 642
2017
Q4 		$3.99M Sell
273,416
-43,313
-14% -$608K ﹤0.01% 889
2017
Q3 		$4.02M Sell
316,729
-106,464
-25% -$1.35M ﹤0.01% 904
2017
Q2 		$5.02M Sell
423,193
-124,271
-23% -$1.55M 0.01% 850
2017
Q1 		$8.09M Buy
547,464
+60,356
+12% +$977K 0.01% 730
2016
Q4 		$7.88M Sell
487,108
-26,538
-5% -$481K 0.01% 724
2016
Q3 		$9.31M Buy
513,646
+275,592
+116% +$5.38M 0.01% 689
2016
Q2 		$3.92M Buy
238,054
+38,638
+19% +$625K ﹤0.01% 902
2016
Q1 		$3.3M Sell
199,416
-49,958
-20% -$874K ﹤0.01% 912
2015
Q4 		$5.4M Sell
249,374
-1,255,449
-83% -$24.4M 0.01% 812
2015
Q3 		$29.8M Buy
1,504,823
+1,339,829
+812% +$42.3M 0.04% 455
2015
Q2 		$5.73M Buy
+164,994
New +$5.04M 0.01% 798
2014
Q3 		– Sell
-58,500
Closed -$925K – 1532
2014
Q2 		$925K Buy
+58,500
New +$835K ﹤0.01% 1232

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American Century Companies's HZNP Position: Q4 2023 in Review

American Century Companies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 27,061 shares — an estimated $3.13M sold.

American Century Companies first reported a position in HZNP in Q2 2014 and held it in 35 quarters. The position peaked at $153M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • American Century Companies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • American Century Companies sold 27,061 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.13M.
  • American Century Companies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 35 quarters.
  • American Century Companies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $153M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.